Approval · Notice of Compliance 1204 · 2000
GEN-HYDROXYUREA: Notice of Compliance 1204
Issued October 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1204
- Date
- October 17, 2000
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antineoplastic agent
- Canadian reference product
- HYDREA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-HYDROXYUREA | 02242920 | Marketed |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP